Sex differences in new-onset heart failure

Clinical Research in Cardiology

Volumn 104, Issue 4, 2015, Pages 342-350

  Meyer, Sven ^a,b   Brouwers, Frank P ^a   Voors, Adriaan A ^a   Hillege, Hans L ^a   de Boer, Rudolf A ^a   Gansevoort, Ron T ^a   van der Harst, Pim ^a   Rienstra, Michiel ^a   van Gelder, Isabelle C ^a   van Veldhuisen, Dirk J ^a   van Gilst, Wiek H ^a   van der Meer, Peter ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Clinic for Cardiology/Heart Center Oldenburg   (Germany)

Author keywords

Gender; Heart failure; Incidence; Risk; Sex

Indexed keywords

AGE DISTRIBUTION; ATRIAL FIBRILLATION; COMORBIDITY; FEMALE; HEART FAILURE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; RISK ASSESSMENT; SEX RATIO; SEXUAL DEVELOPMENT;

AGE DISTRIBUTION; ATRIAL FIBRILLATION; CAUSALITY; COMORBIDITY; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; RISK ASSESSMENT; SEX CHARACTERISTICS; SEX DISTRIBUTION;

EID: 84939994437     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0788-x     Document Type: Article

References (31)

1. Meyer S, van der Meer P, van Deursen VM, Jaarsma T, van Veldhuisen DJ, van der Wal MH, Hillege HL, Voors AA (2013) Neurohormonal and clinical sex differences in heart failure. Eur Heart J 34:2538–2547
2. Meyer S, van der Meer P, Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL, Voors AA (2013) Sex-specific acute heart failure phenotypes and outcomes from PROTECT. Eur J Heart Fail 15:1374–1381
3. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F (2010) Sex-related differences in myocardial remodeling. J Am Coll Cardiol 55:1057–1065
4. Lam CS, Donal E, Kraigher-Krainer E, Vasan RS (2011) Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 13:18–28
5. Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, Levy D (2013) Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail 6:279–286
6. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE, Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777–1782
7. Diercks GF, van Boven AJ, Hillege HL, Janssen WM, Kors JA, de Jong PE, Grobbee DE, Crijns HJ, van Gilst WH (2000) Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. Eur Heart J 21:1922–1927
8. Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH (2013) Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 34:1424–1431
9. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, ESC Committee for Practice Guidelines (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869
10. van Bemmel JH, Kors JA, van Herpen G (1990) Methodology of the modular ECG analysis system MEANS. Methods Inf Med 29:346–353
11. Smilde TD, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL (2006) Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 114:1572–1580
12. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S (1960) The electrocardiogram in population studies. A classification system. Circulation 21:1160–1175
13. Korn EL, Graubard BI (1991) Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 81:1166–1173
14. Graubard BI, Korn EL (1996) Survey inference for subpopulations. Am J Epidemiol 144:102–106
15. Pepe MS, Mori M (1993) Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737–751
16. Fine JPGR (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
17. Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72–80
18. Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801–1811
19. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, Heart disease and stroke statistics–2013 update: a report from the American Heart Association (2013) Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127:e6–e245
20. Scantlebury DC, Borlaug BA (2011) Why are women more likely than men to develop heart failure with preserved ejection fraction? Curr Opin Cardiol 26:562–568
21. Gaasch WH, Zile MR (2011) Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry. J Am Coll Cardiol 58:1733–1740
22. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE, I-PRESERVE Investigators (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124:2491–2501
23. Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM (2012) Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 5:710–719
24. Martinez-Selles M, Doughty RN, Poppe K, Whalley GA, Earle N, Tribouilloy C, McMurray JJ, Swedberg K, Kober L, Berry C, Squire I, on behalf of the Meta-Analysis Global Group In Chronic Heart Failure (MAGGIC) (2012) Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail 14:473–479
25. Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, Ordin DL, Krumholz HM (2003) Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41:217–223
26. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT, Meverden RA, Roger VL (2006) Systolic and diastolic heart failure in the community. JAMA 296:2209–2216
27. Chen HH, Lainchbury JG, Senni M, Bailey KR, Redfield MM (2002) Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Cardiac Fail 8:279–287
28. Regitz-Zagrosek V, Brokat S, Tschope C (2007) Role of gender in heart failure with normal left ventricular ejection fraction. Prog Cardiovasc Dis 49:241–251
29. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA (2005) Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112:2254–2262
30. Coutinho T, Borlaug BA, Pellikka PA, Turner ST, Kullo IJ (2013) Sex differences in arterial stiffness and ventricular-arterial interactions. J Am Coll Cardiol 61:96–103
31. Humphries KH, Kerr CR, Connolly SJ, Klein G, Boone JA, Green M, Sheldon R, Talajic M, Dorian P, Newman D (2001) New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation 103:2365–2370